equine antiserum / Bharat Serums and Vaccines - LARVOL DELTA

PROTECT: Evaluation of Equine Antibody Treatment in Patients With COVID 19 Infection (clinicaltrials.gov) - P1/2 | N=7 | Terminated | Sponsor: Bharat Serums and Vaccines Limited | N=160 ➔ 7 | Trial completion date: Sep 2022 ➔ May 2022 | Active, not recruiting ➔ Terminated; Closed as no eligible patient.

Enrollment change • Trial completion date • Trial termination • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases

PROTECT: Evaluation of Equine Antibody Treatment in Patients With COVID 19 Infection (clinicaltrials.gov) - P1/2 | N=160 | Active, not recruiting | Sponsor: Bharat Serums and Vaccines Limited | Recruiting ➔ Active, not recruiting | Trial primary completion date: Mar 2022 ➔ Aug 2022

Enrollment closed • Trial primary completion date • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases

PROTECT: Evaluation of Equine Antibody Treatment in Patients With COVID 19 Infection (clinicaltrials.gov) - P1/2; N=160; Recruiting; Sponsor: Bharat Serums and Vaccines Limited; Not yet recruiting ➔ Recruiting

Enrollment open • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases

PROTECT: Evaluation of Equine Antibody Treatment in Patients With COVID 19 Infection (clinicaltrials.gov) - P1/2; N=160; Not yet recruiting; Sponsor: Bharat Serums and Vaccines Limited

New P1/2 trial • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases